STOCK TITAN

EOM Pharmaceutical Holdings Stock Price, News & Analysis

IMUC OTC Link

Company Description

Welcome to the overview page for EOM Pharmaceutical Holdings (IMUC), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—
0.00%
0.00
Last updated:
+14.4%
Performance 1 year
$11.3M

SEC Filings

No SEC filings available for EOM Pharmaceutical Holdings.

Financial Highlights

$0
Revenue (TTM)
-$14.3M
Net Income (TTM)
-$16.7M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in EOM Pharmaceutical Holdings (IMUC) currently stands at 40 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 48.7%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for EOM Pharmaceutical Holdings (IMUC) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

Frequently Asked Questions

What is the current stock price of EOM Pharmaceutical Holdings (IMUC)?

The current stock price of EOM Pharmaceutical Holdings (IMUC) is $0.1795 as of February 24, 2026.

What is the market cap of EOM Pharmaceutical Holdings (IMUC)?

The market cap of EOM Pharmaceutical Holdings (IMUC) is approximately 11.3M. Learn more about what market capitalization means .

What is the revenue (TTM) of EOM Pharmaceutical Holdings (IMUC) stock?

The trailing twelve months (TTM) revenue of EOM Pharmaceutical Holdings (IMUC) is $0.

What is the net income of EOM Pharmaceutical Holdings (IMUC)?

The trailing twelve months (TTM) net income of EOM Pharmaceutical Holdings (IMUC) is -$14.3M.

What is the operating cash flow of EOM Pharmaceutical Holdings (IMUC)?

The operating cash flow of EOM Pharmaceutical Holdings (IMUC) is -$16.7M. Learn about cash flow.

What is the current ratio of EOM Pharmaceutical Holdings (IMUC)?

The current ratio of EOM Pharmaceutical Holdings (IMUC) is 2.97, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of EOM Pharmaceutical Holdings (IMUC)?

The operating income of EOM Pharmaceutical Holdings (IMUC) is -$21.2M. Learn about operating income.